Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults

Cenobamate (CNB) is the latest antiseizure medication (ASM) authorized for the treatment of focal-onset seizures in adults. Although the precise mechanism of action of CNB is not yet fully understood, this drug inhibits the persistent, rather than transient, voltage-gated sodium channel currents and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaccara, Gaetano, Lattanzi, Simona, Leo, Antonio, Russo, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643217/
https://www.ncbi.nlm.nih.gov/pubmed/34876814
http://dx.doi.org/10.2147/NDT.S281490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643217/
https://www.ncbi.nlm.nih.gov/pubmed/34876814
http://dx.doi.org/10.2147/NDT.S281490

Ejemplares similares